PubMed

Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity.

Downie LE, Hatzopoulos KM, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Kalloniatis M, Fletcher EL.

J Comp Neurol. 2010 Jan 1;518(1):41-63.PMID: 19882719 [PubMed - in process]Related articles

The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy.

Fletcher EL, Downie LE, Hatzopoulos K, Vessey KA, Ward MM, Chow CL, Pianta MJ, Vingrys AJ, Kalloniatis M, Wilkinson-Berka JL.

Doc Ophthalmol. 2009 Sep 8. [Epub ahead of print]PMID: 19763649 [PubMed - as supplied by publisher]Related articles

(Pro)renin receptor: a treatment target for diabetic retinopathy?

Wilkinson-Berka JL, Campbell DJ.

Diabetes. 2009 Jul;58(7):1485-7. No abstract available. PMID: 19564461 [PubMed - indexed for MEDLINE]Related articlesFree article

Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina.

Downie LE, Vessey K, Miller A, Ward MM, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL.

Neuroscience. 2009 Jun 16;161(1):195-213. Epub 2009 Mar 17.PMID: 19298848 [PubMed - indexed for MEDLINE]Related articles

Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.

Wilkinson-Berka JL, Tan G, Jaworski K, Miller AG.

Circ Res. 2009 Jan 2;104(1):124-33. Epub 2008 Nov 26.PMID: 19038868 [PubMed - indexed for MEDLINE]Related articles

Prorenin and the (pro)renin receptor in ocular pathology.

Wilkinson-Berka JL.

Am J Pathol. 2008 Dec;173(6):1591-4. Epub 2008 Oct 30. Review. No abstract available. PMID: 18974304 [PubMed - indexed for MEDLINE]Related articlesFree article

AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.

Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL.

Glia. 2008 Aug 1;56(10):1076-90.PMID: 18442090 [PubMed - indexed for MEDLINE]Related articles

Update on the treatment of diabetic retinopathy.

Wilkinson-Berka JL, Miller AG.

ScientificWorldJournal. 2008 Feb 6;8:98-120. Review.PMID: 18264628 [PubMed - indexed for MEDLINE]Related articles

Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy.

Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL.

Curr Pharm Des. 2007;13(26):2699-712. Review.PMID: 17897014 [PubMed - indexed for MEDLINE]Related articles

An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.

Wilkinson-Berka JL, Lofthouse S, Jaworski K, Ninkovic S, Tachas G, Wraight CJ.

Mol Vis. 2007 Aug 29;13:1529-38.PMID: 17893652 [PubMed - indexed for MEDLINE]Related articlesFree article

Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.

Downie LE, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Fletcher EL.

J Comp Neurol. 2007 Oct 1;504(4):404-17.PMID: 17663451 [PubMed - indexed for MEDLINE]Related articles

Progressive diabetic nephropathy in the Ren-2 rat.

Kelly DJ, Wilkinson-Berka JL, Gilbert RE.

Am J Physiol Renal Physiol. 2007 May;292(5):F1662; author reply F1663. No abstract available. PMID: 17475900 [PubMed - indexed for MEDLINE]Related articlesFree article

Valsartan but not atenolol improves vascular pathology in diabetic Ren-2 rat retina.

Wilkinson-Berka JL, Tan G, Jaworski K, Ninkovic S.

Am J Hypertens. 2007 Apr;20(4):423-30.PMID: 17386351 [PubMed - indexed for MEDLINE]Related articles

Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.

Phipps JA, Wilkinson-Berka JL, Fletcher EL.

Invest Ophthalmol Vis Sci. 2007 Feb;48(2):927-34.PMID: 17251496 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.

Wilkinson-Berka JL, Wraight C, Werther G.

Curr Med Chem. 2006;13(27):3307-17. Review.PMID: 17168853 [PubMed - indexed for MEDLINE]Related articles

SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.

Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE.

Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1600-5.PMID: 16565398 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin and diabetic retinopathy.

Wilkinson-Berka JL.

Int J Biochem Cell Biol. 2006;38(5-6):752-65. Epub 2005 Sep 1. Review.PMID: 16165393 [PubMed - indexed for MEDLINE]Related articles

Renin inhibition: new potential for an old therapeutic target.

Kelly DJ, Wilkinson-Berka JL, Gilbert RE.

Hypertension. 2005 Sep;46(3):471-2. Epub 2005 Aug 15. No abstract available. PMID: 16103263 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.

Bergman PB, Moravski CJ, Edmondson SR, Russo VC, Bach LA, Wilkinson-Berka JL, Werther GA.

Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2708-15.PMID: 16043842 [PubMed - indexed for MEDLINE]Related articlesFree article

Dysfunction of retinal neurons and glia during diabetes.

Fletcher EL, Phipps JA, Wilkinson-Berka JL.

Clin Exp Optom. 2005 May;88(3):132-45. Review.PMID: 15926876 [PubMed - indexed for MEDLINE]Related articles

The renin-angiotensin system and the developing retinal vasculature.

Sarlos S, Wilkinson-Berka JL.

Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1069-77.PMID: 15728567 [PubMed - indexed for MEDLINE]Related articlesFree article

Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.

Wilkinson-Berka JL.

Curr Pharm Des. 2004;10(27):3331-48. Review.PMID: 15544519 [PubMed - indexed for MEDLINE]Related articles

Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.

Wilkinson-Berka JL, Fletcher EL.

Curr Pharm Des. 2004;10(27):3313-30. Review.PMID: 15544518 [PubMed - indexed for MEDLINE]Related articles

Diabetes and retinal vascular disorders: role of the renin-angiotensin system.

Wilkinson-Berka JL.

Expert Rev Mol Med. 2004 Jul 23;6(15):1-18. Review.PMID: 15387897 [PubMed - indexed for MEDLINE]Related articles

Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.

Wilkinson-Berka JL, Babic S, De Gooyer T, Stitt AW, Jaworski K, Ong LG, Kelly DJ, Gilbert RE.

Am J Pathol. 2004 Apr;164(4):1263-73.PMID: 15039215 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiorenal protective effects of vasopeptidase inhibition with omapatrilat in hypertensive transgenic (mREN-2)27 rats.

Mifsud SA, Burrell LM, Kubota E, Jaworski K, Cooper ME, Wilkinson-Berka JL.

Clin Exp Hypertens. 2004 Jan;26(1):69-80.PMID: 15000298 [PubMed - indexed for MEDLINE]Related articles

Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.

Kelly DJ, Stein-Oakley A, Zhang Y, Wassef L, Maguire J, Koji T, Thomson N, Wilkinson-Berka JL, Gilbert RE.

Nephrology (Carlton). 2004 Feb;9(1):7-13.PMID: 14996301 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II influences ovarian follicle development in the transgenic (mRen-2)27 and Sprague-Dawley rat.

de Gooyer TE, Skinner SL, Wlodek ME, Kelly DJ, Wilkinson-Berka JL.

J Endocrinol. 2004 Feb;180(2):311-24.PMID: 14765984 [PubMed - indexed for MEDLINE]Related articlesFree article

Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.

Mifsud S, Kelly DJ, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE.

Nephron Physiol. 2003;95(4):p83-91.PMID: 14694265 [PubMed - indexed for MEDLINE]Related articles

Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.

Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson-Berka JL.

Am J Pathol. 2003 Sep;163(3):879-87.PMID: 12937129 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition.

Fabiani ME, Hawkes DJ, Frauman AG, Tikellis C, Johnston CI, Wilkinson-Berka JL.

Int J Biochem Cell Biol. 2003 Jun;35(6):973-83.PMID: 12676181 [PubMed - indexed for MEDLINE]Related articles

COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.

Wilkinson-Berka JL, Alousis NS, Kelly DJ, Gilbert RE.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):974-9.PMID: 12601017 [PubMed - indexed for MEDLINE]Related articlesFree article

Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.

Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, Wilkinson-Berka JL, Gilbert RE.

Diabetes. 2003 Feb;52(2):512-8.PMID: 12540629 [PubMed - indexed for MEDLINE]Related articlesFree article

The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.

Moravski CJ, Skinner SL, Stubbs AJ, Sarlos S, Kelly DJ, Cooper ME, Gilbert RE, Wilkinson-Berka JL.

Am J Pathol. 2003 Jan;162(1):151-60.PMID: 12507898 [PubMed - indexed for MEDLINE]Related articlesFree article

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME.

Diabetes. 2002 Nov;51(11):3283-9.PMID: 12401720 [PubMed - indexed for MEDLINE]Related articlesFree article

Characterisation of a thymic renin-angiotensin system in the transgenic m(Ren-2)27 rat.

Wilkinson-Berka JL, Kelly DJ, Rong P, Campbell DJ, Skinner SL.

Mol Cell Endocrinol. 2002 Aug 30;194(1-2):201-9.PMID: 12242043 [PubMed - indexed for MEDLINE]Related articles

Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.

Kelly DJ, Wilkinson-Berka JL, Ricardo SD, Cox AJ, Gilbert RE.

Nephrol Dial Transplant. 2002 Jun;17(6):985-91.PMID: 12032186 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.

Mifsud SA, Skinner SL, Cooper ME, Kelly DJ, Wilkinson-Berka JL.

J Am Soc Nephrol. 2002 Mar;13(3):684-92.PMID: 11856772 [PubMed - indexed for MEDLINE]Related articlesFree article

Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.

Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE.

Kidney Int. 2002 Jan;61(1):31-9.PMID: 11786082 [PubMed - indexed for MEDLINE]Related articlesFree article

The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.

Wilkinson-Berka JL, Kelly DJ, Gilbert RE.

J Vasc Res. 2001 Nov-Dec;38(6):527-35. Review.PMID: 11740151 [PubMed - indexed for MEDLINE]Related articles

Angiotensin and renal fibrosis.

Gilbert RE, Wilkinson-Berka JL, Kelly DJ.

Contrib Nephrol. 2001;(135):171-86. Review. No abstract available. PMID: 11705283 [PubMed - indexed for MEDLINE]Related articles

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.

Mifsud SA, Allen TJ, Bertram JF, Hulthen UL, Kelly DJ, Cooper ME, Wilkinson-Berka JL, Gilbert RE.

Diabetologia. 2001 Jul;44(7):878-82.PMID: 11508273 [PubMed - indexed for MEDLINE]Related articles

Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.

Wilkinson-Berka JL, Gibbs NJ, Cooper ME, Skinner SL, Kelly DJ.

Nephrol Dial Transplant. 2001 Jul;16(7):1343-9.PMID: 11427623 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats.

Rong P, Wilkinson-Berka JL, Skinner SL.

Mol Cell Endocrinol. 2001 Feb 28;173(1-2):203-12.PMID: 11223191 [PubMed - indexed for MEDLINE]Related articles

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.

Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME.

Diabetologia. 2000 Nov;43(11):1360-7.PMID: 11126403 [PubMed - indexed for MEDLINE]Related articles

First report of active renin in rat amniotic fluid.

Caragounis A, Koutsis K, Wlodek ME, Wilkinson-Berka JL, Di Nicolantonio R.

Clin Exp Pharmacol Physiol. 2000 Aug;27(8):631-3.PMID: 10901395 [PubMed - indexed for MEDLINE]Related articles

Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.

Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL.

Kidney Int. 2000 May;57(5):1882-94.PMID: 10792607 [PubMed - indexed for MEDLINE]Related articlesFree article

Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye.

Gilbert RE, Cox AJ, Kelly DJ, Wilkinson-Berka JL, Sage EH, Jerums G, Cooper ME.

Connect Tissue Res. 1999;40(4):295-303.PMID: 10757117 [PubMed - indexed for MEDLINE]Related articles

Retinal neovascularization is prevented by blockade of the renin-angiotensin system.

Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, Shahinfar S, Skinner SL, Wilkinson-Berka JL.

Hypertension. 2000 Dec;36(6):1099-104.PMID: 11116132 [PubMed - indexed for MEDLINE]Related articlesFree article

Renin in thymus, gut, hindlimb, and adrenal of (mRen-2)27 and normal rats: secretion and content studies.

Rong P, Wilkinson-Berka JL, Skinner SL.

Am J Physiol. 1999 Oct;277(4 Pt 1):E639-46.PMID: 10516123 [PubMed - indexed for MEDLINE]Related articlesFree article